TY - JOUR
T1 - Incidence and co-infection with COVID-19 of dengue during the COVID-19 pandemic
AU - Hung, Yuan Pin
AU - Lee, Ching Chi
AU - Chen, Ying Wen
AU - Lee, Jen Chieh
AU - Chiu, Chun Wei
AU - Hsueh, Po Ren
AU - Ko, Wen Chien
N1 - Publisher Copyright:
© 2024 Formosan Medical Association
PY - 2024
Y1 - 2024
N2 - The co-infection of dengue and COVID-19 has been regarded as a public health issue for dengue-endemic countries during the COVID-19 pandemic. Travel restrictions might decrease the chance of mosquitoes biting and, thus, reduce the risk of dengue transmission. However, the spread of dengue was reported to increase with the policies of lockdowns and social distancing in specific areas due to delayed interventions in dengue transmission. Of cases experiencing dengue and COVID-19 co-infection, most recovered after receiving supportive care and/or steroid therapy. However, some episodes of severe or fatal diseases in specific individuals, such as pregnant women, have been reported, and the clinical course of this co-infection is unrecognized or unpredictable. Accordingly, it is crucial to promptly identify predictors of developing severe viral diseases among co-infection patients.
AB - The co-infection of dengue and COVID-19 has been regarded as a public health issue for dengue-endemic countries during the COVID-19 pandemic. Travel restrictions might decrease the chance of mosquitoes biting and, thus, reduce the risk of dengue transmission. However, the spread of dengue was reported to increase with the policies of lockdowns and social distancing in specific areas due to delayed interventions in dengue transmission. Of cases experiencing dengue and COVID-19 co-infection, most recovered after receiving supportive care and/or steroid therapy. However, some episodes of severe or fatal diseases in specific individuals, such as pregnant women, have been reported, and the clinical course of this co-infection is unrecognized or unpredictable. Accordingly, it is crucial to promptly identify predictors of developing severe viral diseases among co-infection patients.
UR - http://www.scopus.com/inward/record.url?scp=85196005443&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85196005443&partnerID=8YFLogxK
U2 - 10.1016/j.jfma.2024.06.007
DO - 10.1016/j.jfma.2024.06.007
M3 - Review article
AN - SCOPUS:85196005443
SN - 0929-6646
JO - Journal of the Formosan Medical Association
JF - Journal of the Formosan Medical Association
ER -